IS7969A - Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi - Google Patents

Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi

Info

Publication number
IS7969A
IS7969A IS7969A IS7969A IS7969A IS 7969 A IS7969 A IS 7969A IS 7969 A IS7969 A IS 7969A IS 7969 A IS7969 A IS 7969A IS 7969 A IS7969 A IS 7969A
Authority
IS
Iceland
Prior art keywords
pyridine derivatives
derivatives useful
exchange systems
calcium exchange
inhibiting sodium
Prior art date
Application number
IS7969A
Other languages
English (en)
Inventor
Otsomaa Leena
Koskelainen Tuula
Karjalainen Arto
Rasku Sirpa
Pollesello Piero
Levijoki Jouko
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8565286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7969(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of IS7969A publication Critical patent/IS7969A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7969A 2003-01-09 2005-08-02 Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi IS7969A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä
PCT/FI2004/000011 WO2004063191A1 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system

Publications (1)

Publication Number Publication Date
IS7969A true IS7969A (is) 2005-08-02

Family

ID=8565286

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7969A IS7969A (is) 2003-01-09 2005-08-02 Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi

Country Status (22)

Country Link
US (1) US7482340B2 (is)
EP (1) EP1583759A1 (is)
JP (1) JP2006516271A (is)
KR (1) KR20050095601A (is)
CN (1) CN100457752C (is)
AR (1) AR042733A1 (is)
AU (1) AU2004203943B2 (is)
BR (1) BRPI0406669A (is)
CA (1) CA2512184A1 (is)
EA (1) EA008539B1 (is)
FI (1) FI20030030A0 (is)
HR (1) HRP20050703A2 (is)
IL (1) IL169435A0 (is)
IS (1) IS7969A (is)
MX (1) MXPA05007435A (is)
NO (1) NO20053730L (is)
NZ (1) NZ541087A (is)
PL (1) PL378326A1 (is)
RS (1) RS20050528A (is)
UA (1) UA81941C2 (is)
WO (1) WO2004063191A1 (is)
ZA (1) ZA200505461B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
JP2010519267A (ja) * 2007-02-22 2010-06-03 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 新規殺微生物剤
EP2649066B1 (en) * 2010-12-06 2015-10-21 Autifony Therapeutics Limited Hydantoin derivatives useful as kv3 inhibitors
EP2524908A1 (en) * 2011-05-20 2012-11-21 LEK Pharmaceuticals d.d. Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
JP5941637B2 (ja) * 2011-09-12 2016-06-29 サノフイ 置換２−（クロマン−６−イルオキシ）−チアゾール及び医薬としてのその使用
SG11201400518RA (en) 2011-09-12 2014-04-28 Sanofi Sa Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
RS53748B1 (sr) * 2011-09-12 2015-06-30 Sanofi Supstituisani 2-(hroman-6-iloksi)-tiazoli i njihova upotreba kao farmaceutskih sredstava
WO2013144191A1 (de) * 2012-03-29 2013-10-03 Bayer Intellectual Property Gmbh Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
TWI633095B (zh) * 2013-03-08 2018-08-21 賽諾菲公司 經取代－６－基氧基－環烷類及其作為醫藥品之用途
GB201416186D0 (en) 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
EP3265445B1 (en) 2015-03-06 2021-05-05 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
AU2016229268B2 (en) 2015-03-06 2020-09-10 Pharmakea, Inc. Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
WO2017030169A1 (ja) * 2015-08-19 2017-02-23 日産化学工業株式会社 液晶配向剤などに用いられる新規なイミド系重合体
CA3036064A1 (en) 2016-09-07 2018-03-15 Pharmakea, Inc. Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making
WO2018048942A1 (en) 2016-09-07 2018-03-15 Pharmakea, Inc. Uses of a lysyl oxidase-like 2 inhibitor
WO2019175464A1 (en) 2018-03-14 2019-09-19 Orion Corporation Compounds useful as inhibitors of sodium-calcium exchanger (ncx)
EP4188552A2 (en) 2020-07-28 2023-06-07 Jazz Pharmaceuticals Ireland Limited Fused bicyclic raf inhibitors and methods for use thereof
CN115850258B (zh) * 2022-12-27 2024-09-24 东北林业大学 一种马赛替尼的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) * 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
US3862232A (en) * 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
BE650081A (is) 1963-07-03
GB1154119A (en) 1968-05-20 1969-06-04 Merck Ag E 3-Alkyl-Flavanones
JPH04113839A (ja) * 1990-09-05 1992-04-15 Mitsubishi Petrochem Co Ltd ポリカーボネート樹脂積層物
FR2733685B1 (fr) * 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
DE69810606T2 (de) 1997-03-27 2003-10-09 Taisho Pharmaceutical Co., Ltd. 2-phenoxyanilinderivate
JPH1149752A (ja) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd フェノキシピリジン誘導体
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DK1031556T3 (da) 1997-10-20 2003-02-24 Taisho Pharmaceutical Co Ltd 2-phenoxyanilinderivater
JPH11302235A (ja) 1998-04-15 1999-11-02 Taisho Pharmaceut Co Ltd フェノキシアルキルアミン誘導体
JP2002542291A (ja) 1999-04-23 2002-12-10 ブリストル−マイヤーズ スクイブ カンパニー ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法
CA2383583C (en) * 1999-09-17 2009-04-07 Nissan Chemical Industries, Ltd. Benzopyran derivative
FI20011507A0 (fi) 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä

Also Published As

Publication number Publication date
NO20053730L (no) 2005-10-07
KR20050095601A (ko) 2005-09-29
PL378326A1 (pl) 2006-03-20
JP2006516271A (ja) 2006-06-29
HRP20050703A2 (en) 2005-10-31
AU2004203943B2 (en) 2009-09-17
FI20030030A0 (fi) 2003-01-09
UA81941C2 (uk) 2008-02-25
MXPA05007435A (es) 2005-09-12
BRPI0406669A (pt) 2005-12-20
CN1745078A (zh) 2006-03-08
ZA200505461B (en) 2006-03-29
NO20053730D0 (no) 2005-08-03
EA008539B1 (ru) 2007-06-29
RS20050528A (sr) 2007-06-04
US20060241147A1 (en) 2006-10-26
EA200501104A1 (ru) 2005-12-29
WO2004063191A1 (en) 2004-07-29
CN100457752C (zh) 2009-02-04
EP1583759A1 (en) 2005-10-12
AU2004203943A1 (en) 2004-07-29
NZ541087A (en) 2008-04-30
CA2512184A1 (en) 2004-07-29
IL169435A0 (en) 2007-07-04
AR042733A1 (es) 2005-06-29
US7482340B2 (en) 2009-01-27

Similar Documents

Publication Publication Date Title
IS7969A (is) Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi
HUS1900052I1 (hu) 2-acilaminotiazol-származékok vagy sóik
IL192053A0 (en) 2-adamantylurea derivatives as selective 11??-hsd1 inhibitors
IS7717A (is) Pýrídasínónafleiður sem PDF4-hemlar
IL166239A0 (en) 2-cyano-4-fluoropyrrolidine derivative or its salt
IS8345A (is) 6-útskipt anilínópúrín sem RTK-tálmar
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
IS7945A (is) 4,5-díarýlþíasólafleiður sem CB-1 tenglar
EP1820101A4 (en) MESSAGE PROFILING SYSTEMS AND METHODS
DE60135560D1 (de) Valsartan salze
DK1569937T3 (da) C-6 modificerede indazolylpyrrolotriaziner
IS7884A (is) Díasepínóindól afleiður sem kínasa hindrar
AU2003300813A8 (en) Thermal barrier coating having low thermal conductivity
IL198462A0 (en) Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors
AU2003275073A8 (en) Low temperature geothermal system
IS8001A (is) Bíarýl setin tríasól sem natríum ganga tálmar
IS7318A (is) Tríasól-kínólínafleiður sem eru gagnlegar sem adenósínviðtakabindlar
EP1654509A4 (en) HEAT TRANSFER SYSTEMS
GB2397086B (en) Flood protection system
EP1623972A4 (en) SOLID N-ACYLALANINE OR SALTS THEREOF
PT103053B (pt) Micro-linha de extrusão
GB0217101D0 (en) Improvements in or relating to basic alarm systems
ES1051435Y (es) Plafon para publicidad en marquesina de paradas de autobuses.
IL163598A0 (en) Dipyridodiazepinones as reverse transcriptase inhibitors
GB0318156D0 (en) Flood prevention system